Head-to-Head Analysis: Smart Leaf (NASDAQ:CLVR) Vs. Medicure (OTCMKTS:MCUJF)

Clever Leaves ( NASDAQ:CLVR – Get Your Free Report ) and Medicure ( OTCMKTS:MCUJF – Get Your Free Report ) are both small-cap medical companies, but which is the better investment? We’ll compare the two companies based on their earnings strength, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership.

Analyst ratings

This is a breakdown of current recommendations and price targets for Clever Leaves and Medicure, as reported by MarketBeat.

Institutional and insider ownership

6.9% of Clever Leaves shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by company insiders. Comparatively, 12.9% of Medicure shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and big money managers believe a stock will outperform the market over the long term.

Risk and volatility

Clever Leaves has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Comparatively, Medicure has a beta of 0.98, suggesting that its share price is 2 % less volatile than the S&P 500.

return

This table compares Clever Leaves and Medicure’s net margins, return on equity and return on assets.

Rating and Earnings

This table compares Clever Leaves and Medicure’s gross revenue, earnings per share (EPS) and valuation.

Medicure has lower revenue but higher earnings than Clever Leaves. Medicure is trading at a lower price-to-earnings ratio than Clever Leaves, indicating that it is currently the more affordable of the two stocks.

Summary

Medicure beats Clever Leaves on 7 of the 11 factors compared between the two stocks.

About Clever Leaves

(Get a free report)

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industry. The company operates through two segments, cannabinoid and non-cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, markets and distributes cannabinoid products that include cannabis flowers, cannabidiol isolates, full-spectrum and standardized extracts and smokable dried flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes and markets nutraceuticals and other natural remedies, wellness products, detoxification products and nutritional and dietary supplements to mass retailers, specialty and health retailers and distributors in the United States. It also manufactures extract products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

About Medicine

(Get a free report)

Medicure Inc., a biopharmaceutical company, is engaged in the research, development and commercialization of human therapeutics for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndromes, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG for the treatment of patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers sodium nitroprusside injection for lowering blood pressure in adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery and for the treatment of acute congestive heart failure. Offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.

Get news and reviews for Clever Leaves daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Clever Leaves and related companies with MarketBeat.com ‘s FREE daily email newsletter.